Scinovex
article Open AccessTop 1% cited

Gelatinase B functions as regulator and effector in leukocyte biology

Journal of Leukocyte Biology · 2001 · Vol. 69(6) · pp. 851–859
Ghislain OpdenakkerPhilippe E. Van den SteenBénédicte DuboisInge NelissenEls Van CoillieStefan MasurePaul ProostJo Van Damme

Abstract

Matrix metalloproteinases (MMPs) form a family of enzymes with major actions in the remodeling of extracellular matrix (ECM) components. Gelatinase B (MMP-9) is the most complex family member in terms of domain structure and regulation of its activity. Gelatinase B activity is under strict control at various levels: transcription of the gene by cytokines and cellular interactions; activation of the pro-enzyme by a cascade of enzymes comprising serine proteases and other MMPs; and regulation by specific tissue inhibitors of MMPs (TIMPs) or by unspecific inhibitors, such as alpha2-macroglobulin. Thus, remodeling ECM is the result of the local protease load, i.e., the net balance between enzymes and inhibitors. Glycosylation has a limited effect on the net activity of gelatinase B, and in contrast to the all-or-none effect of enzyme activation or inhibition, it results in a higher-level, fine-tuning effect on the ECM catalysis by proteases in mammalian species. Fast degranulation of considerable amounts of intracellularly stored gelatinase B from neutrophils, induced by various types of chemotactic factors, is another level of control of activity. Neutrophils are first-line defense leukocytes and do not produce gelatinase A or TIMP. Thus, neutrophils contrast sharply with mononuclear leukocytes, which produce gelatinase A constitutively, synthesize gelatinase B de novo after adequate triggering, and overproduce TIMP-1. Gelatinase B is also endowed with functions other than cleaving the ECM. It has been shown to generate autoimmune neo-epitopes and to activate pro-IL-1beta into active IL-1beta. Gelatinase B ablation in the mouse leads to altered bone remodeling and subfertility, results in resistance to several induced inflammatory or autoimmune pathologies, and indicates that the enzyme plays a crucial role in development and angiogenesis. The major human neutrophil chemoattractant, IL-8, stimulates fast degranulation of gelatinase B from neutrophils. Gelatinase B is also found to function as a regulator of neutrophil biology and to truncate IL-8 at the amino terminus into a tenfold more potent chemokine, resulting in an important positive feedback loop for neutrophil activation and chemotaxis. The CXC chemokines GRO-alpha, CTAP-III, and PF-4 are degraded by gelatinase B, whereas the CC chemokines MCP-2 and RANTES are not cleaved.

Protease and Inhibitor MechanismsSignaling Pathways in DiseaseEnzyme Production and CharacterizationBiologyRegulatorEffectorImmunologyCell biologyInterleukin 10GelatinaseImmune systemGeneticsMatrix metalloproteinase

MeSH terms

Autoimmune DiseasesChromosomes, Human, Pair 20Enzyme ActivationEnzyme InductionExtracellular MatrixHumansLeukocytesLeukocytes, MononuclearNeoplasmsNeutrophilsOrgan SpecificityPhenotypeProtein Processing, Post-TranslationalCytokinesProtein Structure, Tertiary

Funding

  • Cancer Research Foundation
  • University of Oxford
  • Fondation Charcot
Citations
552
FWCI
11.28
field-weighted impact
References
76
Percentile
99%
vs. same field & year
Citations per year
Cited by
References
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.